Suppr超能文献

胆汁酸作为肝脏营养代谢的全局调节因子。

Bile acids as global regulators of hepatic nutrient metabolism.

作者信息

Hylemon Phillip B, Takabe Kazuaki, Dozmorov Mikhail, Nagahashi Masayuki, Zhou Huiping

机构信息

Department of Microbiology and Immunology, Medical College of Virginia Campus, Virginia Commonwealth University, Richmond, VA 23298, USA.

McGuire VA Medical Center, Richmond, VA 23249, USA.

出版信息

Liver Res. 2017 Jun;1(1):10-16. doi: 10.1016/j.livres.2017.03.002. Epub 2017 Apr 26.

Abstract

Bile acids (BA) are synthesized from cholesterol in the liver. They are essential for promotion of the absorption of lipids, cholesterol, and lipid-soluble vitamins from the intestines. BAs are hormones that regulate nutrient metabolism by activating nuclear receptors (farnesoid X receptor (FXR), pregnane X receptor, vitamin D) and G protein-coupled receptors (e.g., TGR5, sphingosine-1-phosphate receptor 2 (S1PR2)) in the liver and intestines. In the liver, S1PR2 activation by conjugated BAs activates the extracellular signal-regulated kinase 1/2 and AKT signaling pathways, and nuclear sphingosine kinase 2. The latter produces sphingosine-1-phosphate (S1P), an inhibitor of histone deacetylases 1/2, which allows for the differential up-regulation of expression of genes involved in the metabolism of sterols and lipids. We discuss here the emerging concepts of the interactions of BAs, FXR, insulin, S1P signaling and nutrient metabolism.

摘要

胆汁酸(BA)在肝脏中由胆固醇合成。它们对于促进肠道中脂质、胆固醇和脂溶性维生素的吸收至关重要。胆汁酸是一类激素,可通过激活肝脏和肠道中的核受体(法尼酯X受体(FXR)、孕烷X受体、维生素D)和G蛋白偶联受体(如TGR5、鞘氨醇-1-磷酸受体2(S1PR2))来调节营养物质代谢。在肝脏中,结合型胆汁酸激活S1PR2可激活细胞外信号调节激酶1/2和AKT信号通路,以及细胞核鞘氨醇激酶2。后者产生鞘氨醇-1-磷酸(S1P),它是组蛋白脱乙酰酶1/2的抑制剂,可使参与固醇和脂质代谢的基因表达差异上调。我们在此讨论胆汁酸、FXR、胰岛素、S1P信号传导与营养物质代谢相互作用的新观点。

相似文献

1
Bile acids as global regulators of hepatic nutrient metabolism.
Liver Res. 2017 Jun;1(1):10-16. doi: 10.1016/j.livres.2017.03.002. Epub 2017 Apr 26.
2
Bile acids and sphingosine-1-phosphate receptor 2 in hepatic lipid metabolism.
Acta Pharm Sin B. 2015 Mar;5(2):151-7. doi: 10.1016/j.apsb.2014.12.009. Epub 2015 Feb 9.
3
Bile acids are nutrient signaling hormones.
Steroids. 2014 Aug;86:62-8. doi: 10.1016/j.steroids.2014.04.016. Epub 2014 May 10.
4
The roles of bile acids and sphingosine-1-phosphate signaling in the hepatobiliary diseases.
J Lipid Res. 2016 Sep;57(9):1636-43. doi: 10.1194/jlr.R069286. Epub 2016 Jul 26.
5
Sphingosine-1-phosphate signaling and the gut-liver axis in liver diseases.
Liver Res. 2019 Mar;3(1):19-24. doi: 10.1016/j.livres.2019.02.003. Epub 2019 Mar 4.
7
Regulation of bile acid receptor activity.
Liver Res. 2018 Dec;2(4):180-185. doi: 10.1016/j.livres.2018.09.008. Epub 2018 Sep 23.
8
Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation.
Nature. 2006 Jan 26;439(7075):484-9. doi: 10.1038/nature04330. Epub 2006 Jan 8.
9
Farnesoid X receptor, the bile acid sensing nuclear receptor, in liver regeneration.
Acta Pharm Sin B. 2015 Mar;5(2):93-8. doi: 10.1016/j.apsb.2015.01.005. Epub 2015 Feb 20.
10
Sphingosine Kinases/Sphingosine 1-Phosphate Signaling in Hepatic Lipid Metabolism.
Curr Pharmacol Rep. 2017 Aug;3:176-183. doi: 10.1007/s40495-017-0093-2. Epub 2017 Jun 20.

引用本文的文献

1
Bile acids and gestational diabetes mellitus: exploring the link and implications - a review.
Front Endocrinol (Lausanne). 2025 Jul 10;16:1574228. doi: 10.3389/fendo.2025.1574228. eCollection 2025.
3
Targeting Sphingosine-1-Phosphate Signaling in Breast Cancer.
Int J Mol Sci. 2024 Mar 15;25(6):3354. doi: 10.3390/ijms25063354.
4
The interaction of bile acids and gut inflammation influences the pathogenesis of inflammatory bowel disease.
Intern Emerg Med. 2023 Nov;18(8):2181-2197. doi: 10.1007/s11739-023-03343-3. Epub 2023 Jul 29.
6
Bile acid-mediated signaling in cholestatic liver diseases.
Cell Biosci. 2023 Apr 29;13(1):77. doi: 10.1186/s13578-023-01035-1.
8
Bile Acids and Biliary Fibrosis.
Cells. 2023 Mar 2;12(5):792. doi: 10.3390/cells12050792.
10
RNA binding protein HuR protects against NAFLD by suppressing long noncoding RNA H19 expression.
Cell Biosci. 2022 Oct 12;12(1):172. doi: 10.1186/s13578-022-00910-7.

本文引用的文献

1
Consequences of bile salt biotransformations by intestinal bacteria.
Gut Microbes. 2016;7(1):22-39. doi: 10.1080/19490976.2015.1127483.
2
Nuclear Receptor Modulation for the Treatment of Nonalcoholic Fatty Liver Disease.
Semin Liver Dis. 2016 Feb;36(1):69-86. doi: 10.1055/s-0036-1571296. Epub 2016 Feb 12.
3
Taurocholate Induces Cyclooxygenase-2 Expression via the Sphingosine 1-phosphate Receptor 2 in a Human Cholangiocarcinoma Cell Line.
J Biol Chem. 2015 Dec 25;290(52):30988-1002. doi: 10.1074/jbc.M115.668277. Epub 2015 Oct 30.
4
TGR5 is essential for bile acid-dependent cholangiocyte proliferation in vivo and in vitro.
Gut. 2016 Mar;65(3):487-501. doi: 10.1136/gutjnl-2015-309458. Epub 2015 Sep 29.
5
Gut-liver axis, nutrition, and non-alcoholic fatty liver disease.
Clin Biochem. 2015 Sep;48(13-14):923-30. doi: 10.1016/j.clinbiochem.2015.06.023. Epub 2015 Jul 4.
7
Bile acids as metabolic regulators.
Curr Opin Gastroenterol. 2015 Mar;31(2):159-65. doi: 10.1097/MOG.0000000000000156.
9
Intestinal transport and metabolism of bile acids.
J Lipid Res. 2015 Jun;56(6):1085-99. doi: 10.1194/jlr.R054114. Epub 2014 Sep 10.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验